Home / Recalls / SterRx, LLC / D-0302-2022

D-0302-2022 Class II Terminated

Recalled by SterRx, LLC — Plattsburgh, NY

Recall Details

Product Type: Drugs
Report Date: January 5, 2022
Initiation Date: November 12, 2021
Termination Date: December 6, 2023
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 24300 bags

Product Description

dilTIAZem HCl 125 mg per 125 mL (1 mg per mL) in 0.7% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-976-01.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

U.S.A. Nationwide

Code Information

Lots S21164/BTV, 3-Dec-21; S21191/BUU, 18-DEC-21; S21197/BUZ, 31-Dec-21; S21220/BVV, 13-Jan-22; S21271/BX0, 27-Jan-22; S21272/BXP, 28-Jan-22; S21299/BYP, 18-Fev-22; S21300/BYQ, 19-Feb-22

Other recalls by SterRx, LLC

D-0930-2023 Class II — Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per m (July 7, 2023)
D-0932-2023 Class II — Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL S (July 7, 2023)
D-0933-2023 Class II — Norepinephrine 16 mg per 250 mL (64 mcg per mL) in 0.9% Sodium Chloride, 250 mL (July 7, 2023)
D-0934-2023 Class II — Norepinephrine 32 mg per 250 mL (128 mcg per mL) in 0.9% Sodium Chloride, 250 mL (July 7, 2023)
D-0931-2023 Class II — Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL S (July 7, 2023)
D-1331-2022 Class II — FentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL (10 mcg per mL) IV bags (July 25, 2022)
D-1332-2022 Class II — fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV (July 25, 2022)
D-0324-2022 Class II — PHENYLephrine HCl, 50 mg per 250 mL, (200 mg per mL) in 0.9% Sodium Chloride Inj (November 12, 2021)
D-0325-2022 Class II — Sodium Bicarbonate in 5% Dextrose Injection, Rx Only, SterRx, 141 Idaho Ave., Pl (November 12, 2021)
D-0316-2022 Class II — Fentanyl Citrate, in 0.9% Sodium Chloride Injection, 1 mg per 100 mL, (10 mcg pe (November 12, 2021)